A detailed history of Ameriprise Financial Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,204,488 shares of NVO stock, worth $125 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,204,488
Previous 1,098,294 9.67%
Holding current value
$125 Million
Previous $157 Million 8.52%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $12.6 Million - $15.4 Million
106,194 Added 9.67%
1,204,488 $143 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $275,606 - $329,959
-2,246 Reduced 0.2%
1,098,294 $157 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $3.91 Million - $5.21 Million
38,302 Added 3.61%
1,100,540 $141 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $780,188 - $937,239
-8,888 Reduced 0.83%
1,062,238 $110 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $52.4 Million - $115 Million
575,818 Added 116.25%
1,071,126 $97.4 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $7.41 Million - $8.21 Million
47,530 Added 10.61%
495,308 $80.2 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $2.91 Million - $3.5 Million
-21,978 Reduced 4.68%
447,778 $71.3 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $324,058 - $427,642
-3,160 Reduced 0.67%
469,756 $63.6 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $10.6 Million - $13 Million
-111,024 Reduced 19.01%
472,916 $47.2 Million
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $24.5 Million - $28.9 Million
-237,206 Reduced 28.89%
583,940 $65.2 Million
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $948,595 - $1.15 Million
-10,189 Reduced 1.23%
821,146 $91.4 Million
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $2.04 Million - $2.49 Million
-21,235 Reduced 2.49%
831,335 $93.2 Million
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $9.19 Million - $11.6 Million
-108,898 Reduced 11.33%
852,570 $82.2 Million
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $2.16 Million - $2.7 Million
31,851 Added 3.43%
961,468 $80.6 Million
Q1 2021

May 17, 2021

BUY
$67.06 - $75.82 $757,509 - $856,462
11,296 Added 1.23%
929,617 $62.7 Million
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $930,813 - $1.08 Million
14,569 Added 1.61%
918,321 $64 Million
Q3 2020

Nov 16, 2020

BUY
$63.69 - $70.22 $12.7 Million - $14 Million
199,330 Added 28.3%
903,752 $62.7 Million
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $39 Million - $45.3 Million
-666,044 Reduced 48.6%
704,422 $46.1 Million
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $26.3 Million - $34.4 Million
-531,488 Reduced 27.94%
1,370,466 $82.5 Million
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $189,268 - $221,154
-3,796 Reduced 0.2%
1,901,954 $110 Million
Q3 2019

Nov 14, 2019

SELL
$47.54 - $53.43 $3.28 Million - $3.68 Million
-68,949 Reduced 3.49%
1,905,750 $98.5 Million
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $4.9 Million - $5.49 Million
-104,715 Reduced 5.04%
1,974,699 $101 Million
Q1 2019

May 15, 2019

SELL
$46.36 - $52.63 $7.75 Million - $8.79 Million
-167,069 Reduced 7.44%
2,079,414 $109 Million
Q4 2018

Feb 14, 2019

BUY
$41.54 - $47.25 $931,700 - $1.06 Million
22,429 Added 1.01%
2,246,483 $104 Million
Q3 2018

Nov 14, 2018

SELL
$46.76 - $51.24 $6.25 Million - $6.85 Million
-133,658 Reduced 5.67%
2,224,054 $105 Million
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $4.31 Million - $4.91 Million
97,307 Added 4.3%
2,357,712 $109 Million
Q1 2018

May 15, 2018

SELL
$48.49 - $58.14 $8.22 Million - $9.85 Million
-169,483 Reduced 6.97%
2,260,405 $111 Million
Q4 2017

Feb 12, 2018

SELL
$47.53 - $53.73 $6.33 Million - $7.16 Million
-133,238 Reduced 5.2%
2,429,888 $131 Million
Q3 2017

Nov 07, 2017

BUY
$41.15 - $49.22 $105 Million - $126 Million
2,563,126
2,563,126 $124 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.